oAlert.pl
WARNING: RECALLED PRODUCT
PL EN

Qutiro

After Qutiro infusion, patients developed chills, chest pain and seizures; blood cultures grew Klebsiella pneumoniae ESBL, indicating infection and a real threat to health or life. Potential effects: sepsis, septic shock, severe complications, death.

Download the app and stay informed

Get instant notifications about recalled products and protect your family.

Qutiro
Risk Level
Critical
Manufacturer
QUESTUS PHARMA PRIVATE LIMITED z siedzibą w Indiach; podmiot, który uzyskał zgodę na czasowe dopuszczenie do obrotu ww. produktu leczniczego: Genesis Pharm sp. z o.o. sp. komandytowa, ul. Obywatelska 128/152, 94-104 Łódź
Batch Number
wszystkie serie (m.in. GL23G-03)
Recall Date
29.03.2024
View official statement

Important Information

What You Should Know

Recommendations

Do not use Qutiro 5 mg/100 ml from any batch. Healthcare facilities should immediately stop its use and apply an alternative medicinal product. Patients who experienced worrying symptoms after adminis...

Actions Taken

The Chief Pharmaceutical Inspector suspended the marketing of Qutiro 5 mg/100 ml (all batches) throughout the country and temporarily prohibited placing it on the market, granting the decision immedia...

Need Help?

If you feel unwell after consuming this product, contact your doctor or call the poison control center.

FAQ

Frequently Asked Questions

Is this product safe to consume?
No. This product has been recalled due to: After Qutiro infusion, patients developed chills, chest pain and seizures; blood cultures grew Klebsiella pneumoniae ESBL, indicating infection and a real threat to health or life. Potential effects: sepsis, septic shock, severe complications, death.
What should I do if I already bought this?
Stop using the product immediately. Return it to the store for a full refund. If you consumed it and feel unwell, contact your doctor.
Which batches are affected?
Affected batch numbers: wszystkie serie (m.in. GL23G-03)

Related

Other Recalled Products